PHARMACOKINETICS AND SAFETY OF GUSELKUMAB, AN ANTI-IL-23 MONOCLONAL ANTIBODY, IN HEALTHY SUBJECTS AND PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN A FIRST-IN-HUMAN STUDY.

Y. Zhuang, C. Calderon, Jr. Marciniak S. J., E. Bouman-Thio,Y. Wasfi,P. Szapary,T. Yang, A. Schantz, H. M. Davis,H. Zhou,Z. Xu

CLINICAL PHARMACOLOGY & THERAPEUTICS（2016）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined